Preferred Name

Sofosbuvir
Synonyms
Definitions

An orally available nucleotide prodrug and a hepatitis C virus (HCV) NS5B polymerase inhibitor with potential HCV inhibiting activity. Upon oral administration, sofosbuvir is metabolized to 2'-deoxy-2'-alpha-fluoro-beta-C-methyluridine-5'-monophosphate, which is then converted into the active triphosphate nucleotide that inhibits the NS5B polymerase, thereby preventing viral replication. The HCV NS5B protein, an RNA-dependent RNA polymerase, is essential for the replication of the viral HCV RNA genome.

ID

http://purl.obolibrary.org/obo/NCIT_C101263

CAS_Registry

1190307-88-0

Chemical_Formula

C22H29FN3O9P

code

C101263

Contributing_Source

CTRP

FDA

definition

An orally available nucleotide prodrug and a hepatitis C virus (HCV) NS5B polymerase inhibitor with potential HCV inhibiting activity. Upon oral administration, sofosbuvir is metabolized to 2'-deoxy-2'-alpha-fluoro-beta-C-methyluridine-5'-monophosphate, which is then converted into the active triphosphate nucleotide that inhibits the NS5B polymerase, thereby preventing viral replication. The HCV NS5B protein, an RNA-dependent RNA polymerase, is essential for the replication of the viral HCV RNA genome.

Display_Name

Sofosbuvir

FDA_UNII_Code

WJ6CA3ZU8B

in_subset

http://purl.obolibrary.org/obo/NCIT_C63923

http://purl.obolibrary.org/obo/NCIT_C173383

http://purl.obolibrary.org/obo/NCIT_C173381

http://purl.obolibrary.org/obo/NCIT_C176424

http://purl.obolibrary.org/obo/NCIT_C116977

http://purl.obolibrary.org/obo/NCIT_C116978

label

Sofosbuvir

NCI_Drug_Dictionary_ID

729636

PDQ_Closed_Trial_Search_ID

729636

PDQ_Open_Trial_Search_ID

729636

Preferred_Name

Sofosbuvir

prefixIRI

NCIT:C101263

prefLabel

Sofosbuvir

PubMedID_Primary_Reference

20845908

Semantic_Type

Pharmacologic Substance

UMLS_CUI

C2976303

subClassOf

http://purl.obolibrary.org/obo/NCIT_C281

http://purl.obolibrary.org/obo/NCIT_C25995

Delete Subject Author Type Created
No notes to display